Table 2. Characteristics of isolates recovered from lung transplant recipients.

Isolate	Organism	MIC (μg/mL)
		C/A	CAZ	IMP	MEM	ATM	FEP	TZP	TGC	CST
1	K. pneumoniae	2	≥64	4	≥16	≥64	≥64	>64/4	0.5	8
2	K. pneumoniae	4	≥64	≥16	≥16	≥64	≥64	>64/4	2	≥16
3	P. aeruginosa	8	≥64	≥16	≥16	≥64	≥64	>64/4	NA	≤0.5
4	K. pneumoniae	8	≥64	≥16	≥16	≥64	≥64	>64/4	2	≥16
5	K. pneumoniae	8	≥64	≥16	≥16	≥64	≥64	>64/4	0.5	0.5
6	K. pneumoniae	0.5	≥64	≥16	≥16	≥64	≥64	>64/4	1	16
7	K. pneumoniae	<0.125	≥64	≥16	≥16	≥64	≥64	>64/4	≤0.5	≤0.5
8	K. pneumoniae	4	≥64	8	≥16	≥64	≥64	>64/4	0.5	2
9	K. pneumoniae	4	≥64	8	≥16	≥64	≥64	>64/4	0.5	2
10	K. pneumoniae	2	≥64	≥16	≥16	≥64	≥64	>64/4	2	≤0.5

NA, not available; C/A, ceftazidime-avibactam; CAZ, ceftazidime; IMP, imipenem; MEM, meropenem; ATM, aztreonam; FEP, cefepime; TZP, piperacillin-tazobactam; TGC, tigecycline; CST, colistin.